Ethiopian Food and Drug Authority (EFDA) Opens Medicine Safety Center

• The Ethiopian Food and Drug Authority has inaugurated a new medicine Safety Monitoring and Coordination Center at Arba Minch University hospital.
• The center will enhance the nation's capacity for monitoring and coordinating pharmaceutical safety, aligning with international best practices.
• Pharmaceutical companies operating in Ethiopia will need to comply with the new safety monitoring and coordination procedures.

The establishment of the Safety Monitoring and Coordination Center is part of EFDA's broader regulatory framework aimed at ensuring the safe use of pharmaceuticals.

The Ethiopian Food and Drug Authority (EFDA) has launched a new medicine Safety Monitoring and Coordination Center at Arba Minch University's comprehensive and teaching specialized hospital. The center, inaugurated on June 24, 2025, is expected to enhance the nation's capacity for monitoring and coordinating pharmaceutical safety. This development marks a significant step forward in EFDA's efforts to ensure the quality and safety of medicines available in Ethiopia.

The establishment of the Safety Monitoring and Coordination Center is part of EFDA's broader regulatory framework aimed at ensuring the safe use of pharmaceuticals. The center will serve as a hub for collecting, analyzing, and disseminating information on medicine safety, enabling EFDA to identify potential risks and take prompt action to mitigate them. This initiative aligns with international best practices in pharmaceutical regulation and demonstrates Ethiopia's commitment to protecting public health.

The opening of the Safety Monitoring and Coordination Center has significant implications for pharmaceutical companies operating in Ethiopia. To comply with the new safety monitoring and coordination procedures, these companies will need to adapt their operations and submit regular reports on their products' safety profiles. This development may lead to increased costs and administrative burdens for some companies, but it also presents opportunities for those that can demonstrate a commitment to quality and safety.

This development may impact pharmaceutical companies operating in Ethiopia, as they will need to comply with the new safety monitoring and coordination procedures.

Source: Original reporting via 𝐄𝐅𝐃𝐀 𝐎𝐩𝐞𝐧𝐬 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐯𝐢𝐠𝐢𝐥𝐚𝐧𝐜𝐞 𝐂𝐞𝐧𝐭𝐞𝐫